Implantable Cardioverter-Defibrillator Eligibility After Initiation of Sacubitril/Valsartan in Chronic Heart Failure: Insights From PROVE-HF
G. Michael Felker, Javed Butler, Nasiren E. Ibrahim, Ileana L. Piña, Alan S. Maisel, Devavrat Bapat, Alexander Camacho, Jonathan H. Ward, Kristin Williamson, Scott D. Solomon, James L. Januzzi, for the PROVE-HF Investigators
Topics & Concepts
Sacubitril, ValsartanMedicineSacubitrilHeart failureValsartanInternal medicineLibrary scienceGerontologyCardiologyEjection fractionComputer scienceBlood pressureHeart Failure Treatment and ManagementCardiac pacing and defibrillation studiesCardiac electrophysiology and arrhythmias